Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities

The advent of stem cell-derived cerebral organoids has already advanced our understanding of disease mechanisms in neurological diseases. Despite this, many remain without effective treatments, resulting in significant personal and societal health burden. Antisense oligonucleotides (ASOs) are one of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Jenny, Zhou, Haiyan, McTague, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274522/
https://www.ncbi.nlm.nih.gov/pubmed/35836547
http://dx.doi.org/10.3389/fnmol.2022.941528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274522/
https://www.ncbi.nlm.nih.gov/pubmed/35836547
http://dx.doi.org/10.3389/fnmol.2022.941528

Ejemplares similares